Iron: the new advances in therapy.

Area of Science:

• Hematology
• Internal Medicine
• Clinical Therapeutics

Background:

• Iron-deficiency syndromes are prevalent and negatively impact patient outcomes, increasing transfusion risks.
• These syndromes encompass absolute iron deficiency, functional iron deficiency, and iron sequestration, often co-existing in hospitalized patients.
• Diagnosis and management of co-existing iron deficiencies present significant clinical challenges.

Purpose of the Study:

• To highlight the emerging role of iron as a safe and effective therapy for iron-deficiency syndromes.
• To discuss the utility of available intravenous iron formulations in restoring body iron levels.
• To underscore the potential for single-episode treatment with intravenous iron.

Main Methods:

• Review of current clinical understanding and therapeutic approaches for iron-deficiency syndromes.
• Analysis of the safety and efficacy profiles of various intravenous iron formulations.
• Consideration of data from ongoing clinical trials.

Main Results:

• Iron is recognized as a safe and effective therapeutic agent for iron-deficiency syndromes.
• Intravenous iron formulations can effectively restore body iron levels, with potential for single-treatment efficacy.
• Ongoing clinical trials are expected to further validate the use of these products.

Conclusions:

• Intravenous iron therapy presents a promising and effective treatment strategy for patients with iron-deficiency syndromes.
• The availability of multiple formulations enhances treatment options for restoring iron homeostasis.
• Further clinical data will solidify the established role of intravenous iron in managing anemia and related conditions.